pharmaceutical preparations for the treatment of pervasive development disorders, dysautonomias, topical infections, wounds, alopecia, celiac disease and influenza; pharmaceutical preparations for the treatment of microbial infections, including bacterial, viral and prion diseases; pharmaceutical preparations for the treatment of cystic fibrosis, pancreatic dysfunction and related disorders; pharmaceutical preparations for the treatment of neuropsychiatric and mental health disorders

pharmaceutical preparations for the treatment of pervasive developmental disorders and dysautonomia